MedTrace Logo

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

NCT04222647 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2021-12-23

No results posted yet for this study

Summary

The aim of the study is to investigate the efficacy and tolerability of a lactic acid containing vaginal suppository with respect to the application in post-menopausal women with VVA.

Conditions

  • Vulvovaginal Atrophy

Interventions

DRUG

WO533

Intravaginal application

Sponsors & Collaborators

  • proDERM Institut für Angewandte Dermatologische Forschung GmbH

    collaborator UNKNOWN

  • Bremer Pharmacovigilance Service GmbH

    collaborator OTHER

  • Dr. August Wolff GmbH & Co. KG Arzneimittel

    lead INDUSTRY

Principal Investigators

  • Kirstin Deuble-Bente, MD · proDERM Institute for Applied Dermatological Research, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-27
Primary Completion
2020-08-11
Completion
2020-08-11

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04222647 on ClinicalTrials.gov